Viewing Study NCT00736905

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:11 AM
Ignite Modification Date: 2026-07-04 @ 7:34 AM
Study NCT ID: NCT00736905
Status: COMPLETED
Last Update Posted: 2010-04-28
First Post: 2008-08-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function.
Sponsor: Tibotec Pharmaceuticals, Ireland
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV View
None AIDS View
None Hepatic Impairment View
Keywords:

Keywords

Keyword Brief Keyword Text View
None TMC278-TiDP6-C130 View
None TMC278-C130 View
None healthy volunteer View
None hepatic impairment View
None HIV Infections View